In addition, several population-based studies have reported that higher serum NT-proBNP levels are significantly associated with greater risk of cardiovascular disease (CVD), suggesting that serum NT-proBNP has potential as a biomarker for estimating future cardiovascular risk in general populations [5–8]. Here, NPPB is linked to cardiovascular disorder.